Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis - Wikidata - awgldk - TriplyDB

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

http://www.wikidata.org/entity/Q34777926

about

New Antituberculosis Drugs: From Clinical Trial to Programmatic Use Tuberculosis Biomarkers: From Diagnosis to Protection PET/CT imaging of Mycobacterium tuberculosis infection Integrated therapy for HIV and tuberculosis New agents for the treatment of drug-resistant Mycobacterium tuberculosis Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic review.Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2 Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?Effects of Fluroquinolones in Newly Diagnosed, Sputum-Positive Tuberculosis Therapy: A Systematic Review and Network Meta-Analysis Transformative tools for tackling tuberculosis Treatment of Drug Susceptible Pulmonary Tuberculosis Translating genomics research into control of tuberculosis: lessons learned and future prospects World TB Day 2016: an interview with leading experts in tuberculosis research Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective Current strategies to treat tuberculosis Recent Developments and Future Opportunities in the Treatment of Tuberculosis in Children Assessment of treatment response in tuberculosis Driving the Way to Tuberculosis Elimination: The Essential Role of Fundamental Research Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure The Effectiveness and Safety of Fluoroquinolone-Containing Regimen as a First-Line Treatment for Drug-Sensitive Pulmonary Tuberculosis: A Systematic Review and Meta-Analysis The best of respiratory infections from the 2015 European Respiratory Society International Congress A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)In silico evaluation and exploration of antibiotic tuberculosis treatment regimens A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant Tuberculosis Tuberculosis therapy for 2016 and beyond.Insights into the pharmacokinetic properties of antitubercular drugs.Challenges in the clinical assessment of novel tuberculosis drugs.Evaluation of the Antibody in Lymphocyte Supernatant Assay to Detect Active Tuberculosis.Pharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment duration Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis.Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies.Spectinamides are effective partner agents for the treatment of tuberculosis in multiple mouse infection models Importance of Drug Pharmacokinetics at the Site of Action Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.Update in Mycobacterium tuberculosis lung disease 2014.Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis.Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial.Advancing host-directed therapy for tuberculosis.

P2860

Q26741138-D2D57B23-9BD4-488B-A7C0-4B6C359E00E2 Q26741141-A676C938-B878-4AE2-A89C-8978EF0F6D81 Q26748493-99898AFC-FE63-463F-AB16-AA8D2E76E04A Q26749428-7AB4A1EB-5468-45D1-A4EB-79C094D78C9F Q26751463-C74C5E4E-DAEA-4AAA-B8B5-29A2CEDF5F1A Q26752616-C2B38C1B-0FCE-4FE5-9CBA-EBF77EE14045 Q26765051-D10F6037-EB67-485E-BF1E-AAABB3D5D8B2 Q26771848-BF6B0656-EC63-43AF-8B3D-559B285B0A30 Q26771997-327F885F-3D0C-44C1-85A5-24066C0BC0BA Q26775757-55539284-430A-4235-9876-48C991259BED Q26784084-FD8672D2-3118-4B73-9840-EDDA6DF1FD78 Q26801605-A261E882-141A-4D4B-A4AB-19DE505DFF13 Q27023437-10BFE653-79E6-47A5-A6B9-0FCE21855A44 Q27304811-B5231A0E-6BAB-4597-B305-401626B2A230 Q28074085-51822764-7D30-47B4-BC5D-E89A35919332 Q28075252-43BA1248-7284-47F6-8445-AB7BFCF3703C Q28085210-06AF0C44-ACFC-4625-A602-110D051F5654 Q28384421-10A7CE52-E781-40FE-80F5-7AEA241A3278 Q28388018-1584586D-1771-4220-96FD-D9B0AC2EC93C Q28391110-E96B91A7-1396-43C7-8F97-7B161E18636C Q28553119-F1A8560B-AA23-47D1-8643-FA95DDF849E2 Q28598393-FD2ABE7F-8BCC-47EB-AE28-8934FF3AFD11 Q28602112-C23889FA-EA3B-4304-8B78-9CADF73E9090 Q28607283-A987001D-01A2-4385-B184-0C906ED6C244 Q29048653-0843693F-06C3-42F8-8F15-85DCC7CA22D4 Q30248788-AF5C9D48-A362-41F1-8DEE-D80C6B10551C Q30251497-4B2261F2-10D0-418A-91E2-6260E625571D Q30251933-24F89F9F-FAA1-4D46-9D45-F153BF9D5459 Q30275004-A699BACE-AD4C-4860-9F3D-C61BFBDC4C3B Q30377051-0A9F8F5E-346C-4AFE-B50A-95F12A0A3C50 Q30379233-2510B7CA-216E-45C0-9ABF-88B97442E5E5 Q30830344-D937A77C-09C1-491C-927F-922CCDA7CDA7 Q30901894-F2C4180D-DEFB-4318-82EE-7B5ADBFC0EEA Q33589762-2A0D59A8-569B-4FFA-ABD6-CE9C8A79A33C Q33648045-50E58512-8CD4-44E1-A2DE-499EAD3A5D79 Q33735589-DC8CA1BB-7824-4073-AB86-8661FD8E8BEF Q33735642-059747D9-77CA-4B56-B7C7-48E2A7951686 Q33801345-9E637B2A-1D02-476B-8F56-CD27E5E4E186 Q33810454-4D72CAE4-3583-4463-ADF8-E58B0A3A0E82 Q34466861-F1BD6A71-67BD-4BDC-8CA3-3D5D9B213753

P2860

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

http://www.wikidata.org/entity/Q34777926

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

@ast

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

@en

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

@nl

type

label

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

@ast

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

@en

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

@nl

prefLabel

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

@ast

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

@en

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

@nl

P1433

Q34777926-0B36612A-592D-42D3-B1D7-FB1C2210B05A

P1476

Q34777926-67516C89-CFD6-4903-8D73-9DF5334889DF

P2093

Q34777926-613A2B5E-B230-4BF4-BA36-14123131DEBB

Q34777926-62445419-FCC4-4E5F-9602-85BFDE472F91

Q34777926-72334058-67D5-4395-ADD1-E639290DA1F3

Q34777926-7DE7BF3F-3772-4714-B6D1-AFC7663C874F

Q34777926-BA2BA951-DE5C-469A-B141-744695C5BC16

Q34777926-E83994DB-09D2-4464-9608-915F838FB85B

P2860

Q34777926-08CFC620-E2F8-4879-A555-AAA2A6C749CA

Q34777926-18F4DA94-34C0-4F75-B5DA-9F4B2EF1C80B

Q34777926-214D39A5-C72E-4053-9E5F-CAF3779A441F

Q34777926-27680469-7CD0-40E2-B095-6C448C6AC4C4

Q34777926-2A14745B-5D77-4A28-BD54-4579C442A4A7

Q34777926-2F44C274-8C13-42D3-8D3C-D24EC0EA0E4E

Q34777926-31B12BDF-5466-4554-A699-9AEE31179544

Q34777926-32BDFC4B-3A97-4677-BFB3-B4FEE7BD3060

Q34777926-3A46D2E4-9F6C-450A-81B3-F6AC62C441EB

Q34777926-4AD8D7E0-1B92-428F-9D63-FB3900D9842E

P304

Q34777926-81859FFD-F96D-452C-8A61-A711C07F01F6

P31

Q34777926-3A075813-F122-4DB4-BAE6-F99AB4933287

P356

Q34777926-EB26C341-E11D-4573-B9A5-C7008A0B258B

P407

Q34777926-544E1232-5B8A-401F-8227-DF77BCD718CA

P433

Q34777926-394838B9-0880-4487-BE24-0F2B4CBE1B2B

P478

Q34777926-D6FBC651-D702-4D91-9C95-9447EB64187E

P50

Q34777926-15DDC8D4-BCBF-4DDD-9CD1-E5D54B0ADF7E

Q34777926-2F10887A-AFA4-4047-8829-CE6D29C71360

Q34777926-3CD91B6A-3091-48A3-B813-1C96608D4120

Q34777926-E5C7973E-6511-4C20-A997-32ECE2950314

P577

Q34777926-53352547-171F-4CCD-AC17-DE65B14383BE

P698

Q34777926-A939D6B7-5839-4224-83DB-E4E9119177C4

P921

Q34777926-029FE20B-E536-4981-804F-EA509D9EDD73

P932

Q34777926-1A1D96C3-766D-491F-8CAB-BE02D95DA388

P356

P1433

The New England Journal of Medicine

P1476

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

@en

P2093

Angela M Crook

http://www.w3.org/2001/XMLSchema#string

Carl M Mendel

http://www.w3.org/2001/XMLSchema#string

Frances Pappas

http://www.w3.org/2001/XMLSchema#string

REMoxTB Consortium

http://www.w3.org/2001/XMLSchema#string

Sarah K Meredith

http://www.w3.org/2001/XMLSchema#string

Stephen R Murray

http://www.w3.org/2001/XMLSchema#string

P2860

Outpatient gatifloxacin therapy and dysglycemia in older adults

Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis

Activity of moxifloxacin against mycobacteria

Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial

Pharmacokinetics of a once-daily oral dose of moxifloxacin (Bay 12-8039), a new enantiomerically pure 8-methoxy quinolone.

Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers.

A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.

Fluoroquinolone-associated tendinopathy: a critical review of the literature.

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.

P304

1577-1587

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1407426

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

371

http://www.w3.org/2001/XMLSchema#string

P50

Timothy D. McHugh

Patrick Phillips

Stephen H Gillespie

P577

2014-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25196020

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

4277680

http://www.w3.org/2001/XMLSchema#string